
Open Your Free Demat Account
Enjoy low brokerage on delivery trades
BAJAJ BROKING
Granules India shares fell 10% after the USFDA inspection at the Gagillapur facility. The company is working on addressing the six observations made during the inspection.
Granules India Ltd shares dropped by 10% to ₹609 as of 11:45 AM on September 12, 2024, after the company’s Gagillapur facility in Hyderabad underwent a USFDA inspection. The inspection, which took place between August 26 and September 6, 2024, resulted in six observations related to Current Good Manufacturing Practice (cGMP) and Pre-Approval Inspection (PAI) processes.
Granules India has assured that it is taking necessary measures to address these observations and plans to submit a detailed response to the USFDA within the required timeframe. The Gagillapur facility is crucial for the company, as it manufactures Finished Dosages (FDs) and Pharmaceutical Formulation Intermediates (PFIs), supporting its global operations.
The share price dip comes despite the company reporting a strong financial performance in Q1 FY25. Granules India's EBITDA rose by 90% year-on-year, with an EBITDA margin of 22%, an improvement of 800 basis points from the previous year. This robust performance underlines the company’s operational strength, even as it works to resolve the regulatory observations.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading